This provider's $6.8M in total Medicare payments ranks in the 86th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 550% from 2022 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 550% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $98.90 | $38.17 | 2.59x | $60.73 | $908.2K | 23.8K | 14 |
| 2023 | $107.38 | $38.22 | 2.81x | $69.16 | $5.9M | 154.5K | 26 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 108.9K | $3.7M | $34.38 | 2.78x |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 23.5K | $1.6M | $68.76 | 2.77x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 16.2K | $557.6K | $34.39 | 2.78x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 7.4K | $253.0K | $34.39 | 2.78x |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 6.2K | $214.6K | $34.39 | 2.78x |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 6.2K | $214.0K | $34.39 | 2.78x |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 334 | $46.5K | $139.37 | 2.74x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 1.2K | $42.2K | $34.39 | 2.76x |
| 87506 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets | 160 | $39.8K | $248.70 | 2.87x |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 904 | $31.1K | $34.39 | 2.75x |
| 81003 | Automated urinalysis test | 5.7K | $12.5K | $2.20 | 2.87x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 134 | $9.8K | $73.50 | 2.87x |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | 180 | $6.2K | $34.39 | 2.73x |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 150 | $5.2K | $34.39 | 2.76x |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 146 | $5.0K | $34.39 | 2.74x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 123 | $3.0K | $24.50 | 2.87x |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | 74 | $2.5K | $34.39 | 2.74x |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 43 | $2.2K | $50.28 | 3.06x |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1.2K | $50.28 | 2.55x |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 34 | $1.2K | $34.39 | 2.76x |
This provider submits charges 2.78 times higher than what Medicare actually pays.
A markup ratio of 2.78x means for every $100 Medicare pays, this provider initially charges $278. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CO for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America | Englewood, CO | $139.3M | ⚠️ Flagged |
| Biodesix, Inc. | Boulder, CO | $52.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data